These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

813 related items for PubMed ID: 22855146

  • 1. Tyrosine-kinase mutations in c-KIT and PDGFR-alpha genes of imatinib naïve adult patients with gastrointestinal stromal tumours (GISTs) of the stomach and small intestine: relation to tumour-biological risk-profile and long-term outcome.
    Søreide K, Sandvik OM, Søreide JA, Gudlaugsson E, Mangseth K, Haugland HK.
    Clin Transl Oncol; 2012 Aug; 14(8):619-29. PubMed ID: 22855146
    [Abstract] [Full Text] [Related]

  • 2. Molecular characterization of an Italian series of sporadic GISTs.
    Origone P, Gargiulo S, Mastracci L, Ballestrero A, Battistuzzi L, Casella C, Comandini D, Cusano R, Dei Tos AP, Fiocca R, Garuti A, Ghiorzo P, Martinuzzi C, Toffolatti L, Liguria GIST Unit, Bianchi Scarrà G.
    Gastric Cancer; 2013 Oct; 16(4):596-601. PubMed ID: 23291969
    [Abstract] [Full Text] [Related]

  • 3. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor.
    Heinrich MC, Corless CL, Demetri GD, Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den Abbeele AD, Druker BJ, Kiese B, Eisenberg B, Roberts PJ, Singer S, Fletcher CD, Silberman S, Dimitrijevic S, Fletcher JA.
    J Clin Oncol; 2003 Dec 01; 21(23):4342-9. PubMed ID: 14645423
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of patients with advanced gastrointestinal stromal tumor of small bowel: implications of imatinib mesylate.
    Yeh CN, Chen TW, Wu TJ, Hsueh S, Jan YY.
    World J Gastroenterol; 2006 Jun 21; 12(23):3760-5. PubMed ID: 16773696
    [Abstract] [Full Text] [Related]

  • 6. Correlation of imatinib resistance with the mutational status of KIT and PDGFRA genes in gastrointestinal stromal tumors: a meta-analysis.
    Lee JH, Kim Y, Choi JW, Kim YS.
    J Gastrointestin Liver Dis; 2013 Dec 21; 22(4):413-8. PubMed ID: 24369323
    [Abstract] [Full Text] [Related]

  • 7. High-resolution melting analysis is a sensitive diagnostic tool to detect imatinib-resistant and imatinib-sensitive PDGFRA exon 18 mutations in gastrointestinal stromal tumors.
    Künstlinger H, Binot E, Merkelbach-Bruse S, Huss S, Wardelmann E, Buettner R, Schildhaus HU.
    Hum Pathol; 2014 Mar 21; 45(3):573-82. PubMed ID: 24444465
    [Abstract] [Full Text] [Related]

  • 8. KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs).
    Lasota J, Miettinen M.
    Semin Diagn Pathol; 2006 May 21; 23(2):91-102. PubMed ID: 17193822
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular analysis of secondary kinase mutations in imatinib-resistant gastrointestinal stromal tumors.
    Lim KH, Huang MJ, Chen LT, Wang TE, Liu CL, Chang CS, Liu MC, Hsieh RK, Tzen CY.
    Med Oncol; 2008 May 21; 25(2):207-13. PubMed ID: 18488160
    [Abstract] [Full Text] [Related]

  • 11. [Translational research and diagnosis in GIST].
    Wardelmann E.
    Pathologe; 2012 Nov 21; 33 Suppl 2():273-7. PubMed ID: 22968735
    [Abstract] [Full Text] [Related]

  • 12. Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors.
    Agaram NP, Wong GC, Guo T, Maki RG, Singer S, Dematteo RP, Besmer P, Antonescu CR.
    Genes Chromosomes Cancer; 2008 Oct 21; 47(10):853-9. PubMed ID: 18615679
    [Abstract] [Full Text] [Related]

  • 13. Is exon mutation analysis needed for adjuvant treatment of gastrointestinal stromal tumor?
    Sendur MA, Ozdemir NY, Akinci MB, Uncu D, Zengin N, Aksoy S.
    World J Gastroenterol; 2013 Jan 07; 19(1):144-6. PubMed ID: 23326179
    [Abstract] [Full Text] [Related]

  • 14. Oncogene mutational analysis in imatinib naive population of gastrointestinal stromal tumor patients.
    Ali Abuderman AW, M Aldakheel F.
    Cell Mol Biol (Noisy-le-grand); 2020 Dec 31; 66(8):26-32. PubMed ID: 34174973
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.
    Debiec-Rychter M, Cools J, Dumez H, Sciot R, Stul M, Mentens N, Vranckx H, Wasag B, Prenen H, Roesel J, Hagemeijer A, Van Oosterom A, Marynen P.
    Gastroenterology; 2005 Feb 31; 128(2):270-9. PubMed ID: 15685537
    [Abstract] [Full Text] [Related]

  • 18. [Differences in clinicopathological features, gene mutations, and prognosis between primary gastric and intestinal gastrointestinal stromal tumors in 1061 patients].
    Li JX, Sun L, Zhao S, Shao B, Guo YH, Chen S, Liang H, Sun Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Apr 25; 26(4):346-356. PubMed ID: 37072312
    [Abstract] [Full Text] [Related]

  • 19. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M, Sobin LH, Lasota J.
    Am J Surg Pathol; 2009 Sep 25; 33(9):1267-75. PubMed ID: 19440146
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.